Rajesh Kuppusamy
پژوهشگر · Medicinal and biomolecular chemistry
University of New South Walesمعرفی
Dr. Rajesh Kuppusamy is a dedicated researcher at the University of New South Wales within the Faculty of Medicine & Health. His expertise spans medicinal chemistry and analytical techniques including HPLC, GPC, LCMS, and NMR for drug molecule analysis. With extensive experience in both industry and academia, Dr. Kuppusamy has developed novel compounds targeting serious human diseases such as cancer, cardiovascular conditions, and bacterial infections.
Dr. Kuppusamy's research focuses on the design and synthesis of new antimicrobial peptides and peptidomimetics to combat various pathogens including bacteria, fungi, and viruses. His work encompasses:
- Isolation of bacteriophages for therapeutic applications
- Investigating the mode of action of antibacterial compounds
- Exploring self-assembly properties of peptidomimetic compounds for drug-delivery applications
- Development of aerosolized disinfectants
His research interests center on medicinal and biomolecular chemistry, with particular emphasis on antimicrobial development. Dr. Kuppusamy applies his expertise in analytical chemistry to quantify and analyze drug molecules, while also leveraging his skills in microbiology to conduct various assays and experiments. His work bridges the gap between fundamental chemical research and practical applications in healthcare, particularly in addressing antibiotic resistance and developing novel therapeutic approaches.
Dr. Kuppusamy has received notable recognition for his research, including:
- BridgeTech REDI Fellowship through MTP connects ($10,000)
- Academic Research Excellence Research Award by the School of Optometry and Vision Science at UNSW
His research has resulted in numerous publications, patents, and conference presentations, demonstrating his significant contributions to the field of medicinal chemistry and antimicrobial development. Dr. Kuppusamy has secured research funding for projects including the development of aerosolized disinfectants, highlighting the practical applications and industry relevance of his work.
Dr. Kuppusamy is actively engaged in translating research into new products that benefit both working organizations and society. His current focus on developing new antibiotics, antivirals, and disinfectants addresses critical challenges in community and hospital-acquired infections, positioning his work at the forefront of public health solutions.
